Germany
Japan
United Kingdom
China
Lenti ORF particles, ILDR2 (Myc-DDK tagged) - Human immunoglobulin-like domain containing receptor 2 (ILDR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
cDNA Clones
USD 1,908.00
6 Weeks
Lenti ORF particles, ATRN (Myc-DDK tagged) - Human attractin (ATRN), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, FFAR4 (Myc-DDK tagged) - Human omega-3 fatty acid receptor 1 (O3FAR1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CCR8 (Myc-DDK tagged) - Human chemokine (C-C motif) receptor 8 (CCR8), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 2,148.00
3 Weeks
Lenti ORF particles, ABCB1 (Myc-DDK-tagged)-Human ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MUC4 (Myc-DDK-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SPNS3 (Myc-DDK-tagged)-Human spinster homolog 3 (Drosophila) (SPNS3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, GHR (Myc-DDK-tagged)-Human growth hormone receptor (GHR), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, IL1RL2 (Myc-DDK tagged) - Human interleukin 1 receptor-like 2 (IL1RL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MUC4 (Myc-DDK-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,176.00
6 Weeks
Lenti ORF particles, TGFBR2 (Myc-DDK tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MCL1 (Myc-DDK-tagged)-Human myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), nuclear gene encoding mitochondrial protein, transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human PERP, TP53 apoptosis effector (PERP), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human bone marrow stromal cell antigen 2 (BST2), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of CALCRL (Myc-DDK-tagged)-Human calcitonin receptor-like (CALCRL)
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human delta-like 4 (Drosophila) (DLL4), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human immunoglobulin-like domain containing receptor 2 (ILDR2), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human attractin (ATRN), transcript variant 1, Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of MUC4 (Myc-DDK-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 4
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of SPNS3 (Myc-DDK-tagged)-Human spinster homolog 3 (Drosophila) (SPNS3)
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of PTGER3 (Myc-DDK-tagged)-Human prostaglandin E receptor 3 (subtype EP3) (PTGER3), transcript variant 5
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human interleukin 1 receptor-like 2 (IL1RL2), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of MUC4 (Myc-DDK-tagged)-Human mucin 4, cell surface associated (MUC4), transcript variant 5
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
USD 768.00
3 Weeks
Lenti ORF clone of Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 (KIR3DL3), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of SPNS2 (Myc-DDK-tagged)-Human spinster homolog 2 (Drosophila) (SPNS2)
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti-ORF clone of MCL1 (Myc-DDK-tagged)-Human myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), nuclear gene encoding mitochondrial protein, transcript variant 3
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, IFNGR2 (Myc-DDK tagged) - Human interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, VSIG4 (Myc-DDK tagged) - Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TIMD4 (Myc-DDK tagged) - Human T-cell immunoglobulin and mucin domain containing 4 (TIMD4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, AXL (Myc-DDK tagged) - Human AXL receptor tyrosine kinase (AXL), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, GP2 (Myc-DDK tagged) - Human glycoprotein 2 (zymogen granule membrane) (GP2), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,000.00
3 Weeks
Lenti ORF particles, ERBB3 (Myc-DDK tagged) - Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, CADM1 (Myc-DDK tagged) - Human cell adhesion molecule 1 (CADM1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, HAVCR1 (Myc-DDK tagged) - Human hepatitis A virus cellular receptor 1 (HAVCR1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1, Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, TRPV1 (Myc-DDK tagged) - Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, UPK2 (Myc-DDK tagged) - Human uroplakin 2 (UPK2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, TNFSF4 (Myc-DDK tagged) - Human tumor necrosis factor (ligand) superfamily, member 4 (TNFSF4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human klotho (KL), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Active filters
Tags
- Myc-DDK
Vectors
- pLenti-C-Myc-DDK-P2A-Puro
Mammalian Cell Selection
- Puromycin
Families
- Transmembrane
Brands
- LentiORF
Filter by
Target Symbol
- NRG1 (36)
- BDNF (33)
- CD1E (26)
- DAG1 (25)
- OPRM1 (25)
- ASPH (24)
- CD46 (24)
- FGFR1 (22)
- ST3GAL3 (20)
- ADGRG2 (18)
- CSF2RA (18)
- FCAR (18)
- FGFR2 (18)
- HFE (18)
- MOG (18)
- PTGER3 (18)
- CDH23 (16)
- CHRM2 (16)
- CMTM1 (16)
- FXYD3 (16)
- SLITRK2 (16)
- STRA6 (16)
- TRPM3 (16)
- ADGRG1 (15)
- ATP2A3 (14)
- CPT1B (14)
- FCRLA (14)
- MUC1 (14)
- PROM1 (14)
- PTCH1 (14)
- SIGLEC10 (14)
- SLC11A2 (14)
- TSPAN4 (14)
- ZFYVE27 (14)
- APP (13)
- ENTPD1 (13)
- GABRA1 (13)
- ABCG1 (12)
- ADAM15 (12)
- ARMC10 (12)
- ASTN2 (12)
- BTNL8 (12)
- CLDND1 (12)
- CLEC7A (12)
- HHAT (12)
- HTR4 (12)
- IL1RAP (12)
- IL5RA (12)
- LDLR (12)
- LDLRAD4 (12)
- LST1 (12)
- NIPA2 (12)
- NRP2 (12)
- P2RX2 (12)
- PTPRO (12)
- SEMA6D (12)
- SEZ6L (12)
- SIGLEC6 (12)
- SLC12A6 (12)
- SLC8A3 (12)
- TMEM25 (12)
- TMEM91 (12)
- TNFRSF25 (12)
- TRPC4 (12)
- YIF1B (12)
- TNFSF13 (11)
- ACBD4 (10)
- ADAM22 (10)
- AGTRAP (10)
- AIFM1 (10)
- B3GALNT1 (10)
- B3GALT5 (10)
- BLCAP (10)
- BTN2A2 (10)
- CD164 (10)
- CD36 (10)
- CD44 (10)
- CD8B (10)
- CEACAM1 (10)
- CKLF (10)
- CLEC2D (10)
- CUTA (10)
- CYB561D1 (10)
- DPP10 (10)
- EDA (10)
- FCGR2B (10)
- FXYD6 (10)
- GCNT1 (10)
- GDNF (10)
- GHRL (10)
- GPR137 (10)
- ICAM2 (10)
- IGSF1 (10)
- KCNJ1 (10)
- KCNMB3 (10)
- KCNQ2 (10)
- KCNQ5 (10)
- KIAA0319 (10)
- MGAT1 (10)
- MIA2 (10)
Species
Lentivirus
Mutants
Pathways
- Metabolic pathways (1006)
- Neuroactive ligand-receptor interaction (784)
- Olfactory transduction (684)
- Cytokine-cytokine receptor interaction (551)
- Cell adhesion molecules (CAMs) (426)
- Calcium signaling pathway (364)
- Hematopoietic cell lineage (293)
- Pathways in cancer (292)
- MAPK signaling pathway (221)
- Regulation of actin cytoskeleton (184)
- Alzheimer's disease (178)
- Jak-STAT signaling pathway (174)
- Natural killer cell mediated cytotoxicity (174)
- Dilated cardiomyopathy (160)
- Endocytosis (155)
- Antigen processing and presentation (142)
- Hypertrophic cardiomyopathy (HCM) (142)
- Lysosome (140)
- Huntington's disease (139)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (138)
- N-Glycan biosynthesis (136)
- ECM-receptor interaction (134)
- Axon guidance (132)
- Oxidative phosphorylation (132)
- Leukocyte transendothelial migration (128)
- Chemokine signaling pathway (126)
- ABC transporters (120)
- Vascular smooth muscle contraction (118)
- Viral myocarditis (118)
- Focal adhesion (115)
- Parkinson's disease (110)
- Drug metabolism - cytochrome P450 (102)
- Adherens junction (98)
- SNARE interactions in vesicular transport (98)
- Retinol metabolism (96)
- Melanogenesis (93)
- Cardiac muscle contraction (92)
- Purine metabolism (90)
- ErbB signaling pathway (88)
- Systemic lupus erythematosus (88)
- Glycerophospholipid metabolism (86)
- PPAR signaling pathway (86)
- Tight junction (86)
- Adipocytokine signaling pathway (84)
- Colorectal cancer (83)
- Glycosphingolipid biosynthesis - lacto and neolacto series (82)
- Graft-versus-host disease (82)
- Metabolism of xenobiotics by cytochrome P450 (82)
- Autoimmune thyroid disease (78)
- Apoptosis (77)
- Neurotrophin signaling pathway (76)
- Sphingolipid metabolism (76)
- Prostate cancer (75)
- O-Glycan biosynthesis (74)
- Wnt signaling pathway (74)
- Basal cell carcinoma (72)
- Gap junction (70)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (70)
- Taste transduction (68)
- Drug metabolism - other enzymes (66)
- Vibrio cholerae infection (66)
- Allograft rejection (64)
- Androgen and estrogen metabolism (64)
- Melanoma (64)
- Type I diabetes mellitus (64)
- Amyotrophic lateral sclerosis (ALS) (63)
- Arachidonic acid metabolism (62)
- Epithelial cell signaling in Helicobacter pylori infection (62)
- Starch and sucrose metabolism (62)
- Toll-like receptor signaling pathway (62)
- Keratan sulfate biosynthesis (60)
- Ether lipid metabolism (58)
- Fc gamma R-mediated phagocytosis (58)
- Porphyrin and chlorophyll metabolism (58)
- Primary immunodeficiency (58)
- Heparan sulfate biosynthesis (56)
- T cell receptor signaling pathway (56)
- TGF-beta signaling pathway (56)
- Complement and coagulation cascades (54)
- Pancreatic cancer (54)
- GnRH signaling pathway (52)
- Fatty acid metabolism (50)
- Hedgehog signaling pathway (50)
- Long-term depression (50)
- Asthma (48)
- Chondroitin sulfate biosynthesis (48)
- Pyrimidine metabolism (48)
- B cell receptor signaling pathway (46)
- Glycerolipid metabolism (46)
- Ascorbate and aldarate metabolism (44)
- Long-term potentiation (44)
- Glycosphingolipid biosynthesis - globo series (42)
- Linoleic acid metabolism (42)
- Pentose and glucuronate interconversions (42)
- p53 signaling pathway (40)
- Glutathione metabolism (38)
- Notch signaling pathway (38)
- Renin-angiotensin system (38)
- Tyrosine metabolism (38)
- Fc epsilon RI signaling pathway (36)
- Glycosphingolipid biosynthesis - ganglio series (34)
- Chronic myeloid leukemia (32)
- Steroid biosynthesis (32)
- Small cell lung cancer (31)
- Prion diseases (30)
- Bladder cancer (28)
- Progesterone-mediated oocyte maturation (26)
- Biosynthesis of unsaturated fatty acids (24)
- Glioma (24)
- Nicotinate and nicotinamide metabolism (24)
- Renal cell carcinoma (24)
- Riboflavin metabolism (24)
- Non-small cell lung cancer (22)
- Oocyte meiosis (22)
- Pathogenic Escherichia coli infection (22)
- Endometrial cancer (20)
- Glycosaminoglycan degradation (20)
- Insulin signaling pathway (20)
- Ubiquitin mediated proteolysis (20)
- Cytosolic DNA-sensing pathway (18)
- Galactose metabolism (18)
- Primary bile acid biosynthesis (18)
- VEGF signaling pathway (18)
- alpha-Linolenic acid metabolism (18)
- Cyanoamino acid metabolism (16)
- Phosphatidylinositol signaling system (16)
- RIG-I-like receptor signaling pathway (16)
- Selenoamino acid metabolism (16)
- Taurine and hypotaurine metabolism (16)
- Type II diabetes mellitus (16)
- Caffeine metabolism (12)
- Inositol phosphate metabolism (12)
- O-Mannosyl glycan biosynthesis (12)
- Phenylalanine metabolism (12)
- Thyroid cancer (12)
- Tryptophan metabolism (12)
- C21-Steroid hormone metabolism (10)
- Glycine (10)
- Glycolysis / Gluconeogenesis (10)
- Nitrogen metabolism (10)
- beta-Alanine metabolism (10)
- serine and threonine metabolism (10)
- Amino sugar and nucleotide sugar metabolism (8)
- Citrate cycle (TCA cycle) (8)
- Dorso-ventral axis formation (8)
- Limonene and pinene degradation (8)
- NOD-like receptor signaling pathway (8)
- Sulfur metabolism (8)
- Acute myeloid leukemia (7)
- Arginine and proline metabolism (6)
- Base excision repair (6)
- Cell cycle (6)
- Histidine metabolism (6)
- Lysine degradation (6)
- Pantothenate and CoA biosynthesis (6)
- Propanoate metabolism (6)
- Protein export (6)
- Valine (6)
- leucine and isoleucine degradation (6)
- Butanoate metabolism (4)
- Fatty acid elongation in mitochondria (4)
- Other glycan degradation (4)
- Pyruvate metabolism (4)
- Terpenoid backbone biosynthesis (4)
- Maturity onset diabetes of the young (2)
- Ubiquinone and other terpenoid-quinone biosynthesis (2)